Ron Perelman's $410m insurance trial is testing the limits of art valuation
The Art Newspaper
JULY 18, 2025
The insurers dispute the damage, as well as Perelman’s claim that he never attempted to sell the works afterward. Again, the debate focused less on physical condition and more on perception, and its impact on price. But how does a market, increasingly professionalised, complex and litigated, quantify a quality as elusive as “oomph”?
Let's personalize your content